Cambium Biomaterials raised 100 million dollars in Series B funding to scale its AI-driven discovery...
Cambium Biomaterials raised 100 million dollars in Series B funding to scale its AI-driven discovery of advanced polymers for defense and aerospace. By using chemical informatics, the company develops...